Ingredients  of Shimbhala Heart Caps – clinical studies/Trials

Clinical Study-1

A pilot study to clinically evaluate the role of herbomineral compound in the management of essential hypertension

Selected from pubmed : https://www.ncbi.nlm.nih.gov/pubmed

Ayu. 2011 Jul-Sep; 32(3): 329–332.

doi:  10.4103/0974-8520.93908

PMCID: PMC3326876

This article has been selected from and cited by other articles in PMC.

Herbomineral compound Rauwolfia serpentina 150 mg Jahar Mohra Pishti 75 mg Moti Pishti 75 mg

About the Study

This was a prospective observational study done at Shri Ashutosh Maharaj (SAM) Ayurvedic Treatment and Research Centre at Noormahal Punjab, India  . 110 patients of recently diagnosed essential hypertension were selected to be followed-up after giving them herbo-mineral medicine containing Sarpgandha 150 mg, Jahar Mohra Khatai Pishti 75 mg and Moti Pishti 75 mg. twice a day.

Abstract

The objective of this study was to investigate and authenticate  the clinical efcacy of a herbomineral extracts of rauwolfina serpentine  or Sarpgandha 150 mg, Jahar Mohra Khatai Pishti 75 mg and Moti Pishti 75 mg. in essential hypertension.

Observation and Results

There was a decrease in average or mean systolic blood pressure-SBP, diastolic blood pressure-DBP. At end stage of this study  Mean SBP was reduced by 28.1% in Stage II hypertension patients as compared to 13.9% reduction in patients with Stage I hypertension. Reduction in mean DBP was 23.4% in Stage II patients as compared to 9.5% in Stage I patients. Mean MBP was reduced by 25.5% in Stage II patients as compared to 11.3% reduction in Stage I patients. Thus the synergistic action of all these is resulting in a high efficacy and high potency anti-hypertensive remedy /Treatment with the studied extracts of rauwolfina serpentine  or Sarpgandha 150 mg, Jahar Mohra Khatai Pishti 75 mg and Moti Pishti 75 mg. 

No clinically significant adverse drug reaction was seen in patients